Medicare Part D coverage · allopurinol · RxCUI 245422
allopurinol 200 MG Oral Tablet
Per the CMS 2026 Part D formulary file, allopurinol 200 MG Oral Tablet is covered by 10 Medicare Part D plans (0.2% of enrollable products), averaging Tier 1.7, with prior authorization required on 0% of covering formularies.
- 0.2%
- Plan coverage
- 10
- Plans covering
- T1.7
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for allopurinol 200 MG Oral Tablet
Per the CMS 2026 Part D formulary file, allopurinol 200 MG Oral Tablet (RxNorm concept RXCUI 245422, generic name allopurinol) appears on 6 distinct formulary files spanning 10 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 1.7.
Real-world access to allopurinol 200 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 2,262,180 Part D beneficiaries filled allopurinol 200 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $136,919,385 and an average per-beneficiary annual cost of $60.53. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry allopurinol 200 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 6
- Plans covering
- 10
- Coverage rate
- 0.2%
- Tier range
- Tier 1 – Tier 3
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 2,262,180
- Total spending
- $136,919,385
- Avg per beneficiary
- $60.53
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering allopurinol 200 MG Oral Tablet
10 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| PrimeTime Health Plan Aultimate (HMO-POS) | Aultcare Health Insuring Corporation | T1 | No | $0 | OH |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| PrimeTime Health Plan Plus (HMO-POS) | Aultcare Health Insuring Corporation | T1 | No | $36.00 | OH |
| PrimeTime Health Plan Classic (HMO-POS) | Aultcare Health Insuring Corporation | T1 | No | $40.30 | OH |
| Mass General Brigham Advantage (PPO) | Mass General Brigham Health Plan, Inc. | T3 | No | $0 | MA |
| Mass General Brigham Advantage Secure (HMO-POS) | Mass General Brigham Health Plan, Inc. | T3 | No | $62.00 | MA |
| Mass General Brigham Advantage Premier (PPO) | Mass General Brigham Health Plan, Inc. | T3 | No | $79.70 | MA |
| Mass General Brigham Advantage Signature (PPO) | Mass General Brigham Health Plan, Inc. | T3 | No | $147.20 | MA |
Frequently Asked Questions
Is allopurinol 200 MG Oral Tablet covered by Medicare Part D?
Yes, allopurinol 200 MG Oral Tablet is covered by 10 Medicare Part D plans (0.2% of all Part D formularies).
What tier is allopurinol 200 MG Oral Tablet on Medicare Part D plans?
allopurinol 200 MG Oral Tablet averages Tier 1.7 across Part D plans, ranging from Tier 1 to Tier 3.
Does allopurinol 200 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for allopurinol 200 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on allopurinol 200 MG Oral Tablet?
In 2023, total Medicare Part D spending on allopurinol 200 MG Oral Tablet was $136,919,385, covering 2,262,180 beneficiaries. The average spend per beneficiary was $60.53.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- cilostazol 100 MG Oral Tablet T1.7
- dorzolamide 20 MG/ML Ophthalmic Solution T1.7
- erythromycin 0.005 MG/MG Ophthalmic Ointment T1.7
- zolpidem tartrate 10 MG Oral Tablet T1.7
- diclofenac sodium 75 MG Delayed Release Oral Tablet T1.7
- amiloride hydrochloride 5 MG / hydrochlorothiazide 50 MG Oral Tablet T1.7
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA